ClinicalThought

Share

Program Content

Activities

  • First- vs Second-Gen BTKi
    How I Use First-Generation vs Second-Generation BTK Inhibitors in CLL and MCL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 13, 2018

    Expires: April 12, 2019

  • R/R CLL: Venetoclax + R
    How I Use Venetoclax/Rituximab in Relapsed/Refractory CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2018

    Expires: July 23, 2019

  • PI3K Inhibitors in CLL
    The Role of First-Generation vs Second-Generation PI3K Inhibitors in CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 13, 2018

    Expires: September 12, 2019

  • CLL Online Tool
    An Interactive Online Tool Featuring Expert Recommendations for CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 10, 2018

    Expires: October 09, 2019

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

cover img faculity

John C. Byrd, MD

D. Warren Brown Chair of Leukemia Research
Professor of Medicine,
Medicinal Chemistry and Veterinary Biosciences
Director, Division of Hematology
Department of Medicine
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Columbus, Ohio

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

Provided by

ProCE Banner

Supporters

Acerta Pharma AstraZeneca Group

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company